Courtagen Capital acquries assets of Decision Biomarkers - MarketLine Financial Deals

Courtagen Capital acquries assets of Decision Biomarkers

Courtagen Capital acquries assets of Decision Biomarkers - MarketLine Financial Deals
Courtagen Capital acquries assets of Decision Biomarkers
Published Jan 11, 2010
2 pages — Published Jan 11, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Courtagen Capital, LLC, an investment firm, has acquired the assets of Avantra Biosciences Corp. (formerly Decision Biomarkers, Inc.).

  
Source:
Document ID
MA35461_101025
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Courtagen Capital acquries assets of Decision Biomarkers" Jan 11, 2010. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Courtagen-Capital-acquries-assets-of-Decision-Biomarkers-2052-45702>
  
APA:
MarketLine Financial Deals. (2010). Courtagen Capital acquries assets of Decision Biomarkers Jan 11, 2010. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Courtagen-Capital-acquries-assets-of-Decision-Biomarkers-2052-45702>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.